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Abstract
The urinary bladder and associated tract are lined by the urothelium, a transitional epithelium that acts as a specialized
permeability barrier that protects the underlying tissue from urine via expression of a highly specific group of proteins
known as the uroplakins (UP). To date, our understanding of the developmental processes responsible for urothelial
differentiation has been hampered due to the lack of suitable models. In this study, we describe a novel in vitro cell culture
system for derivation of urothelial cells from murine embryonic stem cells (ESCs) following cultivation on collagen matrices
in the presence all trans retinoic acid (RA). Upon stimulation with micromolar concentrations of RA, ESCs significantly
downregulated the pluripotency factor OCT-4 but markedly upregulated UP1A, UP1B, UP2, UP3A, and UP3B mRNA levels in
comparison to naı ¨ve ESCs and spontaneously differentiating controls. Pan-UP protein expression was associated with both
p63- and cytokeratin 20-positive cells in discrete aggregating populations of ESCs following 9 and 14 days of RA stimulation.
Analysis of endodermal transcription factors such as GATA4 and GATA6 revealed significant upregulation and nuclear
enrichment in RA-treated UP2-GFP+ populations. GATA42/2 and GATA62/2 transgenic ESC lines revealed substantial
attenuation of RA-mediated UP expression in comparison to wild type controls. In addition, EMSA analysis revealed that RA
treatment induced formation of transcriptional complexes containing GATA4/6 on both UP1B and UP2 promoter fragments
containing putative GATA factor binding sites. Collectively, these data suggest that RA mediates ESC specification toward a
urothelial lineage via GATA4/6–dependent processes.
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Introduction
Mechanisms regulating the development of epithelial tissues
associated with the mammalian urogenital system are poorly
understood. In particular, the sequential molecular cues necessary
for the specification of the bladder urothelium have yet to be
completely clarified. This transitional epithelium primarily serves
as a highly selective permeability barrier protecting underlying
tissues from toxic urinary components thereby preserving the
integrity of the associated urinary tract and ultimately bladder
and renal function [1]. Various congenital and acquired
abnormalities including bladder and cloacal extrosphy [2],
interstitial cystisis [3], neurogenic bladder secondary to myelo-
meningocele [4], and transitional cell carcinoma [5] are
associated with aberrant urothelial differentiation and subsequent
loss of normal barrier function. In order to devise novel therapies
to address these conditions, an increased understanding of
the regulatory networks involved in urothelial development is
required.
The bladder urothelium is derived from the definitive endoderm
[6], one of the three primary germ layers whose subsequent
patterning and differentiation leads to the formation of a variety of
major organs including the liver, pancreas, lungs, thyroid and
intestines [7]. In the mouse, the definitive endoderm, together with
mesoderm and ectoderm, is formed from the embryonic ectoderm
of the epiblast through the process of gastrulation beginning at
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development begins with the formation of a transient embryonic
cavity called the cloaca located at the caudal end of the hindgut,
which is subsequently partitioned by the urorectal septum into a
ventrally placed primitive urogenital sinus and dorsal anorectal
canal by E8.0 [9–13].
Between E12–15, the urothelium develops from the urogenital
sinus into a multi-layered epithelium composed of axially
subdivided basal, intermediate, and superficial cell layers [14].
Basal cells represent a germinative zone which differentiates
towards the lumen into a pre-maturation population defined as
intermediate cells, and finally into fully differentiated superficial
cells. Throughout the formation of the bladder urothelium,
urothelial cells increase their expression of uroplakins (UP) which
assemble into heterodimers and are essential for proper barrier
function [15–18]. Genetic ablation of one or more uroplakin genes
in mice causes severe retrograde vesicoureteral reflux, hydrone-
phrosis, and renal failure, conditions that mirror certain human
congenital diseases [1]. The ureter and trigone region of the
bladder are also lined by a transitional urothelium thought to be
derived from the mesoderm [19]. This is in contrast to the rest of
the bladder and prostatic urethra which are patterned from the
definitive endoderm, but these tissues are presumed to perform
similar functions [20].
Vitamin A-mediated signaling pathways have been implicated
in critical processes involved in the formation of the bladder from
the urogenital sinus as well as the maintenance of a differentiated
urothelial phenotype. Batourina and colleagues demonstrated that
vitamin-A-rescued transgenic mice deficient in retinaldehyde
dehydrogenase-2, an enzyme crucial for embryonic retinoic acid
synthesis, exhibited a high rate of urogenital sinus abnormalities
ranging in severity from bladder hypoplasia to almost complete
bladder agenesis in which only a rudimentary urogenital sinus was
formed [21]. These defects were found to be similar to
malformations previously reported in vitamin A deficiency studies
in rats [22]. Vitamin A deficiency can also induce keratinizing
squamous metaplasia within the rodent bladder urothelium
wherein the normal transitional epithelial structure becomes
morphologically similar to the epidermis [23].
The major biologically active derivative of vitamin A, all trans
retinoic acid (RA), is known to promote specification of a number
of endodermal phenotypes during development including lung
[24], kidney [25], intestine [26], and pancreas [27], however its
role in urothelium formation is currently unknown. Specific
target genes of RA signaling networks such as the GATA family
of zinc finger transcription factors including GATA4/6 have
been shown to participate in the maturation of extra-embryonic
endoderm derivatives [28,29] as well as cardiac [30] and
bronchial epithelial [31] specification. In situ hybridization
studies have demonstrated that GATA factors are also highly
expressed in the urogenital ridge during bladder formation [32].
These results suggest that these proteins may be targets of
retinoid signaling networks which contribute to urothelial lineage
progression and ultimately play key roles in bladder specification
and maturation.
In vitro models of bladder urothelial specification from
embryonic precursors have the potential to generate novel cell
sources for tissue engineering applications as well as serve as
models of development. In the present study, we demonstrate the
ability of all trans retinoic acid (RA) to induce lineage progression
of murine embryonic stem cells (ESC) toward urothelial fate(s) in
vitro. By interrogating this system, we established the role of
specific GATA factors as essential downstream regulators of RA-
mediated UP expression.
Methods
Cell Culture
Murine ESC (C57BL/6 line, American Type Culture Collection,
Manassas, VA) were expanded on c-irradiated mouse embryonic
fibroblasts in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 15% fetal calf serum (FCS), 100 units/ml
penicillin, 100 mg/ml streptomycin, 0.1 mM nonessential amino
acids, 2 mM L-glutamine, 1% nucleosides, 0.1 mM 2-mercapto-
ethanol, and 10
3 units/ml leukemia inhibitory factor (LIF)
(expansion medium) and maintained in a humidified tissue culture
incubator (37uC, 5% CO2). To induce cellular differentiation,
feeder-depleted ESCs were seeded on 2D native type I collagen
matrices [33] (50,000 cells/cm
2) in DMEM supplemented with
15% FCS, 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml
streptomycin, 0.1 mM nonessential amino acids, 1 mM 1-thiogly-
cerol, and all trans retinoic acid (RA) [0.1–10 mM] and cultured for
up to 14 d with daily medium changes. Spontaneously differenti-
ating controls in the absence of RA were maintained in parallel. In
addition, transgenic ESC lines homozygous null (2/2) for GATA4
[34] or GATA6 [28] were also evaluated for their differentiation
potential in response to RA stimulation.
Construction of the mouse UP2 reporter plasmid and
generation of UP2 stable ESC lines
A 3528 bp fragment of the mouse UP2 gene upstream of the
transcription start site was generated by PCR amplification using
Phusion high-fidelity DNA polymerase (New England Biolabs,
Ipswich, MA) and a mouse UP2 specific primer set (forward: 59-
CGTCTCGAGGATCTCGGCCCTCTTT-39; reverse: 59-GGA-
CTGGATCCTGGAACAGGTG-39). The resulting PCR
fragment was subcloned into the pCR4Blunt vector (Invitrogen,
Carlsbad, CA). DNA sequencing of isolated plasmid clones was
performed on an automated DNA analyzer (Model 3730, Applied
Biosystems, Foster City, CA). The UP2 promoter was then
subcloned into the ClaI + BamHI sites of the pGreenZeo-
SR500VA reporter vector (System Biosciences, Mountain View,
CA). The resulting plasmid, pSR500-mUP2, was further modified
to express G418 resistance. A KpnI/XhoI cassette isolated from
the pPNT plasmid [35] containing the neomycin resistance gene
under the control of the constitutively active PGK promoter was
transferred into the Kpn I + Sal I sites of pSR500-mUP2 to create
the pSR500-NEO-mUP2 plasmid. The pSR500-NEO-mUP2
plasmid was introduced into ESCs by Amaxa nucleofection
(Lonza, Basel, Switzerland) and the cells were plated and
expanded onto G418-resistant MEFs (Applied StemCell, Sunny-
vale, CA) in expansion medium detailed above. Twenty-four h
after nucleofection, G418 (Invitrogen) was added to the medium at
a final concentration of 200 mg/ml and selection was continued for
8 d. Individual clones were isolated and further expanded on MEF
cells in expansion medium supplemented with 20 mg/ml G418 in
order to maintain transgene integration. Clones were subjected to
differentiation analysis detailed above.
mRNA Analysis
Total RNA was extracted from ESC cultures according to the single
step acid-phenol guanidinium method [36] using Trizol reagent
(Invitrogen, Carlsbad, CA). mRNA was enriched from total RNA
using the RNeasy kit (Qiagen Inc., Valencia, CA) according to the
manufacturer’s instructions. cDNA were synthesized using High-
Capacity cDNA Transcription kit (Applied Biosystems, Foster City,
CA) following the manufacturer’s instructions. Real time RT-PCR
reactions were performed and analyzed using the ABI PrismH7900HT
Sequence Detection System (Applied Biosystems) and SDS Plate
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interest and the housekeeping gene, GAPDH, in independent reactions
using the Taqman Universal PCR master mix in combination with
commercially available primers and probes consisting of Assays-on-
Demand
TM Gene Expression kits (Applied Biosystems) following
the manufacturer’s instructions. Expression kits included: UP1A,
Mm01176597_g1; UP1B, Mm00769504_m1 UP2, Mm00447665_
m1; UP3A, Mm00447665_m1, UP3B, Mm00558406_m1, GAPDH,
Mm99999915_g1; OCT-4, Mm00658129_gH; cytokeratin 1, Mm-
00492992_g1; cytokeratin 10, Mm03009921_m1; cytokeratin 18,
Mm01601706_g1; cytokeratin 20, Mm00508106_m1; GATA4,
Mm03053570_s1; GATA5: Mm00484692_m1; GATA6, Mm-
00802636_m1; SOX7, Mm00776876_m1; SOX17, Mm00488363_
m1; FOXA1, Mm00484713_m1; FOXA2, Mm00839704_mH; a-
fetoprotein, Mm00431715_m1; PEM, Mm00476718_m1; p63,
Mm00495788_m1; CXCR4, Mm01292123_m1; HOXA13, Mm-
00433967_m1; smooth muscle myosin heavy chain (SM-MHC),
Mm00443013_m1; nestin, Mm03053244_s1; PDX1, Mm00435565_
m1; and Nkx3.1 Mm00440479_m1. For each cDNA sample, the
threshold cycle (Ct) was defined as the cycle number at which
amplification of the target gene was within the linear range of the
reaction. Relative expression levels for each gene of interest were
calculated by normalizing the target gene transcript level (Ct) to the
respective GAPDH level as described previously (2
2DDCt formula,
Perkin Elmer User Bulletin #2).
Immunocytochemistry and Immunohistochemistry
Cells were fixed with neutral buffered formalin and UP, p63,
CK20, a-actin, and GATA4/6 expression was detected by
immunofluorescence using the following primary antibodies: anti-
pan-uroplakin [rabbit antisera raised against total bovine uroplakin
extracts, TT Sun from New York University, 1:100 dilution], anti-
p63[SantaCruz Biotechnology,Santa Cruz, CA,antimouse,1:200
dilution], anti-CK20 [Santa Cruz Biotechnology, anti-rabbit, 1:200
dilution], anti-a-actin [Sigma-Aldrich, anti-mouse, 1:200] anti-
GATA4 [Santa Cruz Biotechnology, anti-rabbit, 1:200] and
GATA6 [Santa Cruz Biotechnology, anti-rabbit, 1:200] followed
by incubation with species-matched Cy3, FITC, or Texas Red-
conjugated secondary antibodies. For experiments demonstrating
co-localization of UP2-GFP+ cells with GATA4/6 expression, GFP
expression was enhanced utilizing an anti-GFP primary antibody
(Abcam, Cambridge, MA, anti-mouse, 1:200) followed by detection
with a FITC-conjugated secondary antibody. Nuclei were counter-
stained with 49, 6-diamidino-2-phenylindole (DAPI), and specimens
were visualized using an Axioplan2 fluorescence microscope (Carl
ZeissMicroImaging,Thornwood,NY).Inaddition,adult C57BL/6
mice were euthanized according to IACUC-approved protocols
and urinary bladders were isolated, fixed in neutral-buffered
formalin for 2 h, dehydrated in graded alcohols, paraffin-embedded
and cut into 5 mm thick sections. Sections were analyzed for
urothelial and epithelial markers as described above.
Flow cytometry
Following 14 d of culture, RA-stimulated and spontaneously
differentiating UP2-GFP ESCs were dissociated into a single cell
suspension and quantified for GFP fluorescence on a FACScaliber
flow cytometer (BD Biosciences, Franklin Lakes, NJ). Untransfected
ESCs either maintained as controls or differentiated similarly were
analyzed in parallel in order to controlfor background fluorescence.
CellQuest 3.0 software (BD Biosciences) was used to acquire and
analyze FACScan data. In some experiments, GFP+ populations
were sorted and collected from RA-treated UP2-GFP ESCs
utilizingaMoFlohigh-speedsorter(Dako-Cytomation,Carpinteria,
CA) and subjected to further analysis detailed below.
Protein Analysis
Whole cell lysates were retrieved in 20 mM Tris-Cl, pH 7.4,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 1% Triton X-
100 supplemented with protease and phosphatase inhibitors.
Nuclear extracts were obtained according to methods reported in
the literature [37]. Immunoblot analysis was performed as
described previously [38]. Primary antibodies included: anti-p63
and GATA4/6 as described above.
Electromobility shift analysis
Electromobilityshift analyses (EMSAs) for GATA-4and GATA-6
binding to murine uroplakins 1B and 2 promoter sequences were
carried out as using methods previously described [39]. Briefly, 3–
5 mg of nuclear extract and 0.5 ng of
32P-labeled oligonucleotide
probe were combined in a reaction mix (20 mlr e a c t i o nv o l u m e )
containing 25 mM Tris-HCl, pH 8, 50 mM KCl, 5 mM MgCl2,
0.5 mM EDTA, 8% glycerol, 2 mgo fB S A ,a n d0 . 5mgo fp o l y ( d I -
dC). The reaction was incubated for 20 min at room temperature,
and the DNA-protein complexes were resolved on 5% polyacryl-
amide gels in 0.5X Tris-borate-EDTA (TBE) buffer at 4uC. The gels
were dried, and the complexes were visualized by autoradiography
using a Typhoon Trio variable mode phosphorimager (GE
Healthcare Biosciences, Piscataway, NJ). For competition experi-
ments, a 25-fold molar excess of the cold competitor oligonucleotide
was added simultaneously with the probe. For supershift experi-
ments, a GATA4 or GATA6 antibody (as described above) was
preincubated onice for1 hwith nuclearextractfollowedby addition
of the other components for 20 min at room temperature. Species-
matched IgG antibodies were used in parallel as additional controls.
The following oligonucleotides were used in EMSAs: UP1B
Gata wt, corresponding to putative GATA binding motif present
in 2 kb UP1B promoter fragment (59-GCC TTT GGG GAGATA
GCA CTA ATC TAT-39); UP1B Gata mut1, containing a point
mutation (underlined) in putative GATA binding motif present in
2 kb UP1B promoter fragment (59- GCC TTT GGG GA GGTA
GCA CTA ATC TAT -39); UP1B Gata mut2, containing a dual
point mutation (underlined) in putative GATA binding motif
present in 2 kb UP1B promoter fragment (59- GCC TTT GGG
GA CTTA GCA CTA ATC TAT -39); UP2 Gata wt,
corresponding to putative GATA binding motif present in 2 kb
UP2 promoter fragment (59- GTG TGC ATG TGG ATA AGT
GTG TGT GTG -39); UP2 Gata mut1, containing a point
mutation (underlined) in putative GATA binding motif present in
2 kb UP2 promoter fragment (59- GTG TGC ATG TGG GTA
AGT GTG TGT GTG -39); UP2 Gata mut2, containing a dual
point mutation (underlined) in putative GATA binding motif
present in 2 kb UP2 promoter fragment (59- GTG TGC ATG
TGC TTA AGT GTG TGT GTG -39).
Statistical Analysis
All quantitative measurements were collected with N=3–4
independent determinations per data point and expressed as mean 6
standard deviation. Data for these measurements were analyzed
with Microsoft Excel software utilizing a Student’s two-tailed t-test
assuming equal levels of variance. Statistically significant values were
defined as p,0.05.
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the standards outlined in the National
Research Council’s Guide and Children’s Hospital Boston (CHB)
PHS Assurance, and all animal work was approved by the CHB
Animal Care and Use Committee (IACUC, Protocol 08-09-1207).
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Effect of RA on ESC UP Expression
RA is known to function in both a time- and concentration-
dependent manner to selectively regulate lineage specification
during ESC differentiation [27,40,41]. We first investigated the
ability of continuous cultivation of ESCs in the presence of RA
(0.01–10 mM) to stimulate urothelial marker expression. Real time
RT-PCR analysis demonstrated that withdrawal of LIF as well as
the addition of micromolar concentrations of RA led to the down-
regulation of OCT-4 mRNA transcript levels in ESC cultures,
indicating a progression toward differentiation (Figure 1A). In
addition, RA acted synergistically with LIF withdrawal to promote
pluripotency marker decline. RA stimulation increased mRNA
transcript levels of all five uroplakins (UPs) over those seen in
spontaneously differentiating controls and naı ¨ve ESCs by day 6 of
cultivation with significant elevation occurring by 9 d and
continuing to rise through 14 d of culture (Figure S1). The
ability of RA to stimulate UP expression was concentration-
dependent, with micromolar concentrations stimulating maximal
extents of mRNA transcription over the 9 d time course
(Figure 1B).
Following 14 days of cultivation, RA stimulation (10 mM) of a
stable UP2-GFP ESC line led to substantial upregulation of GFP
fluorescence in discrete cell populations primarily localized within
3-D cellular aggregates dispersed throughout the culture
(Figure 1C). In addition, flow cytometry revealed approximately
2.660.5% of the RA-stimulated population was GFP+ compared
to WT cultures maintained in parallel (Figure 1D). Spontane-
ously differentiating controls and naı ¨ve ESCs demonstrated
negligible GFP fluorescence as assessed by fluroscence microscopy
and flow cytometry analysis. Real time RT-PCR analysis of
endogenous UP2 mRNA transcript levels in sorted GFP+ cell
populations derived from RA-treated cultures demonstrated
substantial elevation of expression in comparison to unfractionated
populations and GFP- fractions (Figure S2). Together, these
Figure 1. RA stimulation of ESCs induces UP expression in a time and concentration-dependent manner. [A] Real time RT-PCR analysis
of UP and OCT-4 expression by ESCs cultured on collagen matrices in the presence (+RA) or absence (C) of 10 mM RA for up to 9 d. (*)=p,0.05, in
comparison to spontaneously differentiating controls and undifferentiated ESCs. [B] Effect of RA concentration on UP expression following 9 d. For
[A–B], levels normalized to GAPDH expression. Mean 6 SD per data point. [C] Photomicrographs of merged phase and GFP expression in
spontaneously differentiating controls and RA-stimulated UP2-GFP ESC line following 14 d of cultivation. Scale bar=80 mm. [D] Flow cytometry
histograms comparing the extent of GFP expression in untransfected (WT) and UP2-GFP ESC lines either as spontaneously differentiating controls (left
panel) or RA-treated cultures following 14 d (right panel). Extent of fluorescence intensity per amount of population events is displayed with shaded
plots representing WT cultures and open plots representing UP2-GFP ESC line.
doi:10.1371/journal.pone.0011513.g001
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correlates with endogenous UP2 transcription.
UP expression is associated with lineage markers
associated with the stratified urothelium of the
urogenital tract
IHC analysis of UP protein expression in the adult murine
bladder demonstrated specific localization throughout each layer
of the urothelium with maximal expression observed in the apical
layer of the superficial umbrella cells lining the lumen
(Figure 2A). Previous studies have reported the expression of
UPs and their assembly into AUM is essential for the
maintenance of urothelial barrier function [15–18]. Transgenic
mice lacking the basal cell marker p63 present severe epithelial
defects, including epidermis and prostate bud agenesis and loss of
basal and intermediate urothelial cell layers [42]. Our results
demonstrated nuclear p63 expression localized to the urothelium
of the murine bladder with detection restricted to basal and
intermediate cell layers. These data were consistent with previous
observations of urothelial marker distribution in the murine
bladder [15–16,42].
UP protein expression was first detected in RA-treated cultures
following 9 d of cultivation and was localized to 2-D cell nests
distributed throughout the culture population (Figure 2B).
Further ICC analysis demonstrated the presence of both p63+
and p63- cell fractions within the UP+ population (Figure 2B).
Immunoblotting demonstrated enrichment of p63 expression in
nuclear fractions of RA-treated cultures compared to spontane-
ously differentiating controls (Figure S3). By 14 d of RA
stimulation, UP expression was further detected in selective 3-D
cell aggregates and peripheral populations (Figure 2C). The
distribution of UP protein was similar to that observed within
UP2-GFP+ subpopulations identified by promoter-reporter assays
detailed above.
Murine urothelium is also characterized by a unique pattern of
cytokeratin (CK) expression. It has been confirmed that among
cytokeratins, CK20 expression is restricted to the superficial cells
of normal adult urothelium [14], while CK18 is expressed in all
Figure 2. RA enrichment of UP+ populations coincides with markers of stratified urothelium. [A] Photomicrographs of adult murine
bladder (C57BL/6) showing native urothelium organization and architecture. Left panel: immunofluorescence of pan-UP expression (red, Cy3)
localized in urothelium. Scale bar=500 mm. Right panel: immunofluorescence of nuclear p63 expression (red, Cy3) localized to the basal and
intermediate urothelial layers (denoted with white arrow). Absence of nuclear p63 staining was noted in superficial urothelial cells (denoted with
yellow arrow). Scale bar=100 mm. For both panels, images were merged with DAPI nuclear counterstain (blue). [B] Photomicrographs of
spontaneously differentiating control and RA-treated ESCs following 9 d of cultivation showing acquisition of epithelial morphology and co-
localization of UP (green, FITC) and nuclear p63 expression (red, Cy3). Pan-UP+ populations merged with DAPI were observed with (denoted with
white arrow) and without (denoted with yellow arrow) p63+ nuclear staining. Scale bar=30 mm. [C] Photomicrographs of phase and
immunofluorescence fields of RA-treated ESCs following 14 d of cultivation. Samples demonstrated 3-D cell aggregates coupled with pan-UP
expression (red, Cy3). DAPI nuclear counterstain (blue). Scale bar=100 mm. [D] Real time RT-PCR analysis of CK18 and CK20 expression in cultures
described in [B]. Levels normalized to GAPDH expression. Mean 6 SD per data point. [E] Photomicrographs of immunofluorescence fields of RA-
treated UP2-GFP ESCs following 14 d of cultivation demonstrated GFP expression colocalized with CK20 expression (red, Cy3). Cells exhibiting co-
staining of GFP and Cy3 are denoted with orange arrows. DAPI nuclear counterstain (blue). Scale bar=60 mm.
doi:10.1371/journal.pone.0011513.g002
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with maturation [14]. Real time RT-PCR analysis of CK18
and CK20 expression in RA-treated ESCs revealed significant
upregulation of mRNA transcript levels over controls (Figure 2D).
However, differential expression kinetics were detected for these
markers wherein CK20 plateaued during the onset of UP
expression (6–9 d) while CK18 peaked following 6 d and declined
by 9 d of treatment. Similar analysis of cytokeratins associated
with vaginal (CK1) and keratinizing (CK10) epithelium [43],
demonstrated negligible induction over controls following 9 d of
RA treatment (data not shown). In addition, ICC revealed robust
CK20 protein expression associated with selective UP2-GFP+
populations within the 3-D cell aggregates present in RA-
stimulated cultures (Figure 2E).
Selective RA concentrations stimulate expression of early
endoderm transcription factors
RA is known to promote differentiation of murine ESCs toward
particular endodermal phenotypes via stimulation of transcrip-
tional networks that mediate embryonic patterning in vivo. In
order to evaluate potential pathways and transcriptional mediators
responsible for urothelial specification, we first assessed the
temporal expression of early endoderm transcription factors,
SOX17 [44] and its associated downstream targets, FOXA1 [45]
and FOXA2 [46] (Figure 3A), as well as GATA 4/5/6
(Figure 3B) in relation to the onset (6–9 d) of RA-mediated UP
expression.
Real time RT-PCR analysis demonstrated significant upregula-
tion of SOX17, GATA4 and GATA6 as early as d 1 following RA
stimulation. Kinetic analysis revealed that SOX17 peaked at 3 d
of RA stimulation and receded to control levels by 9 d. Maximal
upregulation of FOXA1 and FOXA2 was noted at 6–9 d,
presumably as a consequence of increased SOX17 expression.
GATA4 mRNA transcript levels peaked in response to RA at d 3
and plateaued until d 9. ESCs also increased levels of GATA5
and GATA6 expression, both of which peaked at 9 d of
continuous stimulation with RA. These results demonstrate that
RA-mediated upregulation of SOX17, its targets FOXA1 and
Figure 3. RA induction of UP expression is correlated with markers of hindgut definitive endoderm (DE), in contrast to markers of
the extraembryonic endoderm (ExE). [A, B] Real time RT-PCR analysis of endoderm marker expression by ESCs cultured on collagen matrices in
the presence (+RA) or absence (C) of 10 mM RA for up to 9 d. [C] Effect of RA concentration on ESC differentiation markers of ExE or hindgut DE, as
well as various RA-responsive lineages following 9 d of stimulation. For all panels, levels were normalized to GAPDH expression. N=3–4 per data
point.
doi:10.1371/journal.pone.0011513.g003
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with the onset and progression of urothelial marker expression in
ESCs.
Selective RA concentrations stimulate specification of
various types of endoderm and associated derivatives
UP expression is primarily restricted to the urothelial compart-
ment of the urogenital tract. However, several reports have also
described expression of selected UPs at divergent sites throughout
the developing mammalian embryo including UP1B within the
intestines, ocular epithelium, and the tissues of the extra-
embryonic endoderm such as the allantois [47]. Early endodermal
markers such as SOX17 and GATA factors have also been
identified as crucial signaling molecules in directing both
extraembryonic endoderm (ExE) and definitive endoderm devel-
opment [28,34,44,48]. Therefore expression of these markers is
not mutually exclusive for lineage discrimination. To further
understand the origin of urothelial marker expression in ESC
cultures, we investigated the impact of various RA concentration
regimes over a 9 d time course on ExE marker expression and
assessed this trend relative to UP induction (Figure 3C). Real
time RT-PCR analysis demonstrated substantial upregulation of
ExE markers including the global ExE transcription factor, PEM
[49], SOX7 (parietal endoderm) [50], and a-fetoprotein (visceral
endoderm) [51] in response to 0.01–0.1 mM of RA over non-
stimulated controls, while 10 mM RA resulted in no significant
upregulation over control levels. These results demonstrate that
RA modulates progression toward ExE lineages within a
concentration range which is 100-fold less than the optimal
concentration responsible for induction of UP expression in vitro.
Since the bladder urothelium is derived from the definitive
hindgut endoderm following its specification from the urogenital
sinus, we further evaluated the effect of RA concentration on
modulation of markers selective for the development of hindgut
endoderm derivatives and compared this trend to the onset of UP
induction (Figure 3C). CXCR4 has been proposed as a marker of
definitive endoderm [52] and the presence of this protein within
the urinary bladder has been implicated as an important signaling
molecule in mediating normal micturition [53]. The homeobox
(Hox) family of transcription factors also represents crucial
signaling molecules that regulate embryonic patterning and
organogenesis [54]. Studies from Hoxa-132/2 transgenic mice,
have shown the loss of this transcription factor results in a
hypoplastic urogenital sinus with an absence of the presumptive
bladder anlage [55]. Analysis of RA-treated ESC populations
demonstrated significant upregulation of CXCR4 and Hoxa13
Figure 4. Nuclear GATA4 and GATA6 expression is associated with UP expression both in vitro and in vivo. [A] Immunoblot analysis of
nuclear (NUC) and cytoplasmic (CYT) protein fractions demonstrating enrichment of GATA4 and GATA6 in nuclear extracts of wild type (WT) RA-
treated ESCs following 9 d of cultivation. The degree of Ponceau S staining of membranes after transfer was used to indicate uniform sample loading.
[B] Photomicrographs of RA-treated UP2-GFP+ cells co-stained for GFP (green, FITC) and nuclear GATA4/6 (red, Cy3) following 14 d of culture.
Observed populations included: GFP/GATA4/6+ cells (denoted by white arrows), cells positive for GATA4/6 expression alone (denoted by orange
arrows), and GFP+, but GATA4/6 negative cell types (denoted by yellow arrows). Scale bar=500 mm. [C] Photomicrographs of adult murine (C57BL/6)
bladder urothelium showing nuclear localization of GATA4/6 in superficial cells (denoted by white arrows), while exclusion in the basal and
intermediate cell layers (denoted by yellow arrows). Scale bar=40 mm. For both [A, B], images were merged with DAPI nuclear counterstain (blue).
doi:10.1371/journal.pone.0011513.g004
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concentration regimes. Temporal progression of marker expres-
sion corresponded with the induction of urothelial markers and
plateaued with similar kinetics (Figure S4).
UP expression is associated with specific types of RA-
stimulated lineages
Since RA-treated cultures were observed to consist of
morphologically heterogeneous populations, we investigated the
presence of other RA-responsive and/or endodermal-derived
lineages (Figure 3C). In parallel with increased UP expression,
RA in the mM range was sufficient to induce maximal expression
of SM-MHC and nestin, over nonstimulated controls. These
changes are indicative of both SMC and neuronal lineages,
respectively, and are consistent with previous reports [40,56].
Optimal expression of other definitive endoderm lineage markers
including PDX1, representative of pancreatic differentiation [27],
was confined to 0.1 mM RA, while Nkx3.1, a marker of prostate
epithelium [57], another hindgut derivative, was strongly down-
regulated compared to controls. Markers of skeletal muscle, Myf5
[58], and hematopoietic lineages, GATA1 [59], in cultured ESCs
were unresponsive to micromolar concentrations of RA (data not
shown), while the lung epithelial marker, surfactant protein C [60],
was undetectable by real time RT-PCR analysis. These results
suggest that micromolar concentrations of RA are selective for
definitive endoderm progression as opposed to ExE endoderm,
while the former is enriched for the urothelial lineage, in contrast
to certain other gut derivatives. Markers specific for mesoderm
and ectoderm derivatives which populate the bladder such as
SMCs and neurons were induced in parallel with urothelial
differentiation; these divergent lineages may be regulated by a
general RA-mediated mechanism responsible for bladder specifi-
cation.
Role of GATA factors in RA-mediated stimulation of UP
expression
Mechanisms responsible for RA stimulation of UP expression
are unknown. However, our results demonstrate that mRNA
transcript levels of certain GATA factors are upregulated in
parallel during this process. Immunoblot analysis demonstrated
enrichment of GATA4 and GATA6 in nuclear fractions of RA-
treated ESCs over control levels following 9 d of cultivation
(Figure 4A). Nuclear localization of GATA4 and GATA6 was
also evident by ICC analysis in various morphologically distinct
RA-stimulated subpopulations at 6, 9, (Figure S5A) and 14 d of
culture (Figure 4B). Moreover, expression of these GATA factors
was co-localized to certain UP2-GFP+ subpopulations following
14 d of RA stimulation (Figure 4B). IHC staining of murine
bladder urothelium further demonstrated robust nuclear expres-
sion of both GATA4 and GATA6 in superficial umbrella cells
which strongly co-expressed UPs as detected using a pan-uroplakin
antibody (Figure 4C). These results demonstrate that both in
vitro and in vivo expression of UP is associated with the presence
of nuclear GATA4/6.
Similar degrees of GATA4 and GATA6 expression were also
evident in GFP- cell types at 14 d of culture. ICC analysis revealed
that particular GFP- subpopulations not only co-expressed these
GATA factors, but also displayed robust a-actin expression, a
prominent smooth muscle-associated marker [39] (Figure S5B).
These results are consistent with other published reports
demonstrating expression of GATA4 and GATA6 in various
smooth muscle phenotypes [39,61].
Previous reports have demonstrated that knockout mice
deficient in either GATA4 or 6 are embryonic lethal at E6.5–8,
prior to the onset of bladder specification due to deficiencies in
extraembryonic tissue formation [28,34]. To determine the role of
GATA4/6 in the regulation of markers associated with urothelial
differentiation, GATA42/2 and GATA62/2 homozygous null
ESCs were subjected to RA stimulation (10 mM) for 9 d and
compared to wild type (WT) controls. Real time RT-PCR analysis
revealed that mutant ESC lines were capable of expressing low
baseline levels of certain UPs similar to WT controls. However,
RA-treated GATA42/2 ESCs failed to enhance UP1B and UP2
expression in response to RA treatment as compared to
unstimulated controls (Figure 5A). In addition, UP1A and
UP3A expression were significantly attenuated compared to wild
type cultures stimulated with RA in parallel. GATA62/2 ESCs
failed to upregulate mRNA transcript levels of any of the major
UPs (Figure 5B). These results demonstrate that GATA4/6
transcription factors play essential roles in regulating UP
expression in RA-stimulated ESCs.
Murine UP 1B and 2 promoters contain GATA factor
binding sites which recruit GATA4 and GATA6 in
response to RA stimulation
Our observations provide evidence that (1) RA-stimulated UP
mRNA transcript levels are attenuated by the loss of GATA4/6
DNA binding activities and (2) RA stimulation is capable of
enriching certain GATA factors in nuclear fractions of UP2-GFP+
cells (3) murine superficial urothelial cells are capable of co-
expressing GATA4/6 as well as UP. These findings suggest that
GATA 4/6 may be recruited to the promoters of various
uroplakins, thus exerting positive transcriptional control over gene
expression. Previous studies by Lin and colleagues demonstrated
that a 3.6-kb 59-flanking sequence of the mouse UP2 promoter was
sufficient to promote transgene expression exclusively in the
suprabasal cell layers of the urothelium, in a pattern similar to that
of the endogenous UPII gene. These results provide evidence that
many of the cis elements that define the bladder specificity and
differentiation dependence within the UP2 gene reside in this 3.6-
kb sequence [62].
To determine the presence of putative GATA binding elements
within the UP promoters, we analyzed a 2.0 kb fragment upstream
from the transcriptional start site of each murine UP promoter
sequence in silico using commercially available MatInspector
software (Genomatix, Ann Arbor, MI) as previously described
[63]. We identified one putative GATA-binding site within both
the UP1B and UP2 promoter sequences at the following positions
relative to the transcriptional start site: UP1B (2698 to 2710) and
UP2 (21872 to 21885). In addition, promoter regions of the
UP1A, UP3A, UP3B genes contained multiple putative GATA-
binding sites. To determine whether GATA4/6 were recruited to
the UP1B and UP2 promoters, we performed EMSA using
nuclear extracts of RA-treated ESCs and spontaneously differen-
tiating controls. As shown in Figure 6A and 6B, we observed
robust complex formation with labeled probes corresponding to
Figure 5. GATA4 and GATA6 are crucial signaling molecules in RA-mediated upregulation of UP expression in ESCs. Real time RT-PCR
analysis of uroplakin expression in WT, GATA42/2 [A] or GATA62/2 [B] ESCs cultured in the presence (+RA) or absence (C) of 10 mM RA for up to
9 d. ESC(0) = undifferentiated ESCs. Levels normalized to GAPDH expression. Mean 6 SD per data point. N=3–4 per data point. (*)=p,0.05, in
comparison to levels observed with RA-treated WT cultures.
doi:10.1371/journal.pone.0011513.g005
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sequences of RA-treated samples, while control nuclear extracts
showed negligible binding. The complexes were competed out
with the corresponding unlabeled UP1B or UP2 consensus GATA
oligonucleotides, but not with mutant versions of these sequences.
In addition, we observed supershift of the UP1B complex in the
Figure 6. Murine UP1B and UP2 promoters contain GATA-DNA binding sites which recruit complexes containing GATA4/6 in
response to RA stimulation. Nuclear extracts from RA-treated ESCs following 9 d show distinct GATA-DNA complexes with
32P-labeled consensus
oligos specific for GATA binding to 2 kb UP1B [A, C] or UP2 [B, D] promoter fragments. Complexes were absent in spontaneously differentiating
controls (C). Both complexes were inhibited by addition of respective excess unlabeled wild type (wt) but not mutant GATA oligos (m1, m2). [C, D]
The presence of GATA4 (G4) and GATA6 (G6) in both the GATA-UP complexes was determined by supershift or immunodepletion (ID) following
antibody-specific incubation (G4, G6), but not species-matched isotype control antibodies (IgG). NS represents non specific band. FP denotes excess
free probe.
doi:10.1371/journal.pone.0011513.g006
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consistent with the presence of GATA4/6 in the complex.
Supershift was also noted with the UP2 complex in the presence
of GATA4 antibody, but not with IgG control; however the
presence of GATA6 antibody resulted in substantial immunode-
pletion of the UP2 complex (Figure 6D) relative to IgG control.
Together, these data suggest that RA-mediated signals promote
recruitment of GATA4/6 to GATA binding sites within the
UP1B/2 promoters during ESC specification.
Discussion
Previous studies have provided some evidence that ESCs harbor
urothelial differentiation potential in vitro and in vivo. Oottama-
sathien and colleagues reported that ESCs combined with fetal
embryonic mesenchyme were able to form bladder-like structures
expressing UP following 42 d of incubation within a kidney
capsule model [64]. A study by Kinebuchi and colleagues showed
cultivation of ESCs on collagen type I matrices in selective
keratinocyte medium promoted upregulation of UP2 mRNA,
however subcutaneous implantation was needed in order to detect
UP protein expression [65]. The results of the present study
further establish the potential of murine ESC to acquire molecular
and biochemical features associated with urothelial phenotypes.
Our in vitro model is distinct from other systems since RA
promotes expression of all UPs, together with developmental
markers of the definitive endoderm in both a temporal and
concentration-dependent manner in vitro. Our results indicate
that UP-expressing cells generated using this model may originate
specifically from a hindgut definitive endodermal population, in
contrast to lineages of the ExE endoderm, which are also known to
express certain UPs during development. In response to RA
stimulation, lineage analysis of markers of various hindgut
derivatives such as the prostate epithelium demonstrated signifi-
cant down-regulation of Nkx3.1 in comparison to control levels.
These results therefore suggest that UP-expressing populations
observed within our system are unlikely to be associated with this
lineage. In addition, the absence of CK1 upregulation in RA-
treated cultures provides evidence that UP expression was not
derived from vaginal epithelial differentiation.
Localization of UP expression with markers such as p63,
CK20, and GATA4/6 in organized 3-D cellular aggregates
provides evidence that RA stimulation may initiate various
phenotypes associated with stratified urothelium. The presence of
ESC-derived populations co-expressing nuclear p63 in combina-
tion with UPs suggests the presence of basal and intermediate
urothelial lineages, given that similar trends in immunostaining
were observed within the bladder urothelium in vivo. Our
observation that some UP2-GFP+ populations express CK20 and
GATA4/6 may also be evidence of superficial cell formation,
since this cell type displays similar features in vivo [14]. Our
observation that GATA4/6 nuclear localization occurs within the
urothelium represents the first account to our knowledge of the
presence of these transcription factors within this tissue
compartment. In addition, the inability of RA treatment to
upregulate CK10 in our culture system is also consistent with a
lack of keratinizing epithelium which is predominant in the
epidermis as well as in squamous metaplasia of the urothelium
[43]. In addition, the decline in CK18 expression in RA-treated
cultures coupled with the onset of UP expression at d 6 of culture
may also be an indication of the maturation of urothelial
populations, given the transient expression of this marker in vivo
during bladder urothelial development and loss during postnatal
maturation [14].
Collectively, our data suggest that in vitro UP-expressing
populations resemble stratified epithelium from the urogenital
tract. However, since the urothelium of both the bladder and
ureter share many of the same morphological features and
perform similar functions [43], we were unable to discriminate
between these two possible lineages in this study. Previous
urothelial differentiation models deploying ESCs as well as the
results from this study have also demonstrated co-differentiation of
both smooth muscle and neuronal lineages in an RA-responsive
manner. These results may suggest a general RA-mediated
mechanism which governs specification of urogenital-associated
phenotypes from pluripotent stem cell sources.
The ability of RA to stimulate GATA4/6 mRNA and protein
expression, complex formation at GATA-DNA binding sites
within the UP1B and UP2 promoter sequences, and UP induction
in ESCs suggests mechanism(s) by which retinoids modulate
progression of certain urogenital epithelial lineages through
particular GATA transcription factors. Retinoids are known to
primarily facilitate changes in gene expression through binding to
two classes of nuclear receptors, retinoic acid receptors (RARs)
and retinoid X receptors (RXRs), which belong to the nuclear
hormone receptor superfamily of transcription factors [66]. At
least three genes encode each type of receptor (denoted a, b, and
c), and typical responses are transduced through binding of homo-
and hetero-dimers of RAR and RXR receptor complexes to
retinoic acid response elements (RAREs) present in the promoters
of target genes [67]. Although, it is unknown how RA signals
stimulate GATA4/6 expression in this system, previous studies of
pluripotent F9 teratocarcinoma cells have identified GATA4 and
GATA6 as transcriptional targets of RARc [68] and RARb2 [69]
signaling complexes, respectively. These results coupled with
observations from this study may suggest the existence of a
signaling network in murine ESCs wherein selective RAR nuclear
receptor complexes including RARc and RARb2 induce GATA4
and GATA6 expression leading to UP upregulation.
In summary, we described a novel protocol for the urothelial
specification of murine ESCs and implicate RA-mediated
GATA4/6 signaling mechanisms in the regulation of UP
expression. The ability of our differentiation protocol to generate
cell populations exhibiting multiple features of the urothelium is a
potential advantage over other reported systems which require
various periods of in vivo implantation to achieve comparable
results. This feature may allow for isolation and expansion of
clinically relevant populations which could be deployed in
urogenital tissue engineering applications. Future investigations
will focus on interrogating the utility of these ESC-derived
populations to both integrate and contribute to urothelial function
in vivo.
Supporting Information
Figure S1 RA stimulation of ESCs further induces uroplakin
expression from 9 to 14 days of culture. Real time RT-PCR
analysis of UP expression by ESCs cultured on collagen matrices
in the presence (+RA) or absence (C) of 10 mM RA from 9 to 14 d
of culture. Levels normalized to GAPDH expression. Mean 6 SD
per data point.
Found at: doi:10.1371/journal.pone.0011513.s001 (0.44 MB TIF)
Figure S2 Endogenous uroplakin 2 expression of FACS-sorted
UP2-GFP ESC lines in response to RA stimulation. Real-time
RT-PCR analysis of endogenous UP2 expression in UP2-GFP
ESC lines cultured for 14 d in the presence of RA. Samples
consisted of either unfractionated controls, GFP positive and
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Mean 6 SD per data point.
Found at: doi:10.1371/journal.pone.0011513.s002 (0.42 MB TIF)
Figure S3 Enrichment of p63 in nuclear fractions of RA-treated
ESCs. Immunoblot analysis of nuclear (NUC) and cytoplasmic
(CYT) fractions demonstrating enrichment of p63 in nuclear
extracts of wild type (WT) RA-treated ESCs following 9 d of
cultivation.
Found at: doi:10.1371/journal.pone.0011513.s003 (0.49 MB TIF)
Figure S4 RA stimulation of ESCs promotes upregulation of
hindgut definitive endoderm markers in a time dependent manner.
Real time RT-PCR analysis of definitive hindgut endoderm
markers in response to RA stimulation (10 mM) over 9 d of
cultivation. Undifferentiated and spontaneously differentiating
controls (C) were analyzed in parallel. Levels normalized to
GAPDH expression. Mean 6 SD per data point.
Found at: doi:10.1371/journal.pone.0011513.s004 (0.44 MB TIF)
Figure S5 RA stimulation of ESCs promotes temporal expres-
sion of nuclear GATA4/6 in various subpopulations including
SMC phenotypes. [A] Nuclear GATA4/6 expression in RA-
treated ESCs following 6 and 9 d of culture. Scale bar=60 mm.
[B] Photomicrographs of RA-treated ESCs co-stained for a-actin
(green, FITC) and nuclear GATA4/6 (red, Cy3) (denoted by white
arrows) following 14 d of culture. Scale bar=500 mm. For both
[A, B], images were merged with DAPI nuclear counterstain
(blue).
Found at: doi:10.1371/journal.pone.0011513.s005 (9.41 MB TIF)
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